How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports

Health Newsfeed – Johns Hopkins Medicine Podcasts by Johns Hopkins Medicine

GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. Willia...View more